Biomarker ID | 239 |
PMID | 18061988 |
Year | 2006 |
Biomarker | Anterior Gradient 2 Homolog AGR2 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Upregulatated in PCa (3.8 fold) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:- ERN2 human kinase ARCHS4 coexpression, STYK1 human kinase ARCHS4 coexpression, MAPK15 human kinase ARCHS4 coexpression, TNK1 human kinase ARCHS4 coexpression, CDC42BPG human kinase ARCHS4 coexpression |
Experiment | Normal Vs Prostate Cancer |
Type of Biomarker | Diagnostic |
Cohort | 10 prostate cancer and 10 normal serum samples were used for analysis |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0021 |
Method Used | Western Blot |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | AGR2 |